Ljumanovic R, Pouwels P J W, Langendijk J A, Knol D L, van der Valk P, Leemans C R, Castelijns J A
Department of Radiology, VU University Medical Center, Amsterdam, the Netherlands.
AJNR Am J Neuroradiol. 2007 Sep;28(8):1540-6. doi: 10.3174/ajnr.A0599.
Our aim was to retrospectively investigate the prognostic significance of the degree of contrast enhancement in tumors and its additional value in previously considered MR imaging parameters with regard to local control of laryngeal cancer treated with radiation therapy (RT) alone.
Pretreatment MR images of 64 consecutive patients (54 men and 10 women, 43-80 years of age) with supraglottic and glottic cancer were retrospectively reviewed on clinical and previously considered MR imaging parameters such as tumor involvement of specific laryngeal anatomic subsites, including laryngeal cartilages, tumor volume, extralaryngeal tumor spread, and, in addition, the degree of contrast enhancement. Clinical and MR imaging parameters were associated with regard to local control at 2 years by using the Cox regression model. "Local control" was defined as absence of primary tumor recurrence.
When using a threshold of the mean average contrast enhancement of 77%, the 2-year local control rate in the groups of patients with a degree of enhancement below and above this threshold was 57% and 70%, respectively (P=.3). Enhancement of tumor tissue in pre-epiglottic space (PES) was low, most probably due to its adipose tissue and poor vascular content, whereas tumor tissue involving paraglottic space (PGS) did enhance. Results of multivariate analysis indicated that the degree of contrast enhancement yielded the prognostic information (P=.07) with 2 independent prognostic factors: primary tumor volume (P=.007) and subglottic extension (P=.002) with regard to local control. Using these previously mentioned 3 MR imaging parameters as potential risk factors, we defined 4 categories, resulting in the following local control rates respectively: 90% for the group without risk factors, 73% for the group with 1, 60% for the group with 2, and finally 0% for the group with 3 risk factors, which was significantly lower than the rates in previous risk groups (P < .001).
PES has a lower degree of contrast enhancement than the PGS and may correlate with the worse outcome. Including a low degree of contrast enhancement as a parameter to primary tumor volume and subglottic extension may increase the predictive value of MR imaging for local outcome and may be helpful to identify a subset of patients whose tumors all recurred locally within 2 years after primary RT.
我们的目的是回顾性研究肿瘤对比增强程度的预后意义及其在单独接受放射治疗(RT)的喉癌局部控制方面对先前已考虑的磁共振成像(MR)参数的附加价值。
回顾性分析64例连续声门上和声门癌患者(54例男性,10例女性,年龄43 - 80岁)治疗前的MR图像,观察临床及先前已考虑的MR成像参数,如喉特定解剖亚部位的肿瘤累及情况,包括喉软骨、肿瘤体积、喉外肿瘤扩散,此外还有对比增强程度。使用Cox回归模型分析临床和MR成像参数与2年局部控制情况的相关性。“局部控制”定义为无原发肿瘤复发。
当平均对比增强阈值设定为77%时,增强程度低于和高于此阈值的患者组2年局部控制率分别为57%和70%(P = 0.3)。会厌前间隙(PES)内肿瘤组织的增强程度较低,很可能是由于其脂肪组织和血管含量少,而累及声门旁间隙(PGS)的肿瘤组织有增强。多因素分析结果表明,对比增强程度产生了预后信息(P = 0.07),与2个独立的预后因素相关:原发肿瘤体积(P = 0.007)和声门下扩展(P = 0.002)对局部控制的影响。将上述3个MR成像参数作为潜在危险因素,我们定义了4类情况,其局部控制率分别如下:无危险因素组为90%,有1个危险因素组为73%,有2个危险因素组为60%,最后有3个危险因素组为0%,该组显著低于先前危险因素组的局部控制率(P < 0.001)。
PES的对比增强程度低于PGS,可能与较差的预后相关。将低对比增强程度作为原发肿瘤体积和声门下扩展的参数纳入分析,可能会提高MR成像对局部预后的预测价值,并有助于识别一组在原发RT后2年内肿瘤均局部复发的患者。